Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig V Labbate

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Urology|March 3, 2022
Editorial CommentCraig V Labbate, Mehrad Adibi, Surena F Matin
World Journal of Urology|January 12, 2021
Should Grade Group 1 (GG1) be called cancer?Craig V Labbate, Gladell P Paner, Scott E Eggener
Prostate Cancer and Prostatic Diseases|August 17, 2019
Inherited risk assessment of prostate cancer: it takes three to do it rightJianfeng Xu, Craig V Labbate, William B Isaacs, et al.
Urology|February 26, 2022
Incidence of Preoperative Antibiotic Use and Its Association with Postoperative Infectious Complications after Radical CystectomyCraig V Labbate, Kristine Kuchta, Sangtae Park, et al.
Urology|June 16, 2022
AUTHOR REPLYCraig V Labbate, Kristine Kuchta, Sangtae Park, et al.
The Journal of Urology|September 21, 2022
Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer TreatmentCraig V Labbate, Laurence Klotz, Monica Morrow, et al.
Urologic Oncology|April 20, 2020
National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapyCraig V Labbate, Ryan P Werntz, Logan B Galansky, et al.
Urologic Oncology|June 6, 2025
A polygenic risk score is associated with risk of bladder cancer and earlier age of diagnosis, independent of lifestyle factorsDavid J Nusbaum, Zhuqing Shi, Annabelle Ashworth, et al.
The Journal of Urology|November 3, 2023
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center ExperienceAkshay Sood, Jan K Rudzinski, Craig V Labbate, et al.
Urologic Oncology|January 24, 2021
The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysisVignesh T Packiam, Craig V Labbate, Stephen A Boorjian, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Urology|March 3, 2022
Editorial CommentCraig V Labbate, Mehrad Adibi, Surena F Matin
World Journal of Urology|January 12, 2021
Should Grade Group 1 (GG1) be called cancer?Craig V Labbate, Gladell P Paner, Scott E Eggener
Prostate Cancer and Prostatic Diseases|August 17, 2019
Inherited risk assessment of prostate cancer: it takes three to do it rightJianfeng Xu, Craig V Labbate, William B Isaacs, et al.
Urology|February 26, 2022
Incidence of Preoperative Antibiotic Use and Its Association with Postoperative Infectious Complications after Radical CystectomyCraig V Labbate, Kristine Kuchta, Sangtae Park, et al.
Urology|June 16, 2022
AUTHOR REPLYCraig V Labbate, Kristine Kuchta, Sangtae Park, et al.
The Journal of Urology|September 21, 2022
Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer TreatmentCraig V Labbate, Laurence Klotz, Monica Morrow, et al.
Urologic Oncology|April 20, 2020
National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapyCraig V Labbate, Ryan P Werntz, Logan B Galansky, et al.
Urologic Oncology|June 6, 2025
A polygenic risk score is associated with risk of bladder cancer and earlier age of diagnosis, independent of lifestyle factorsDavid J Nusbaum, Zhuqing Shi, Annabelle Ashworth, et al.
The Journal of Urology|November 3, 2023
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center ExperienceAkshay Sood, Jan K Rudzinski, Craig V Labbate, et al.
Urologic Oncology|January 24, 2021
The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysisVignesh T Packiam, Craig V Labbate, Stephen A Boorjian, et al.
Pageof 2